The conference programme will be built around 9 Sessions:

• Enabling Chemistries for Chemical Biology Research
  Chair: Prof. Daniel Harki, University of Minnesota, US
  
  
• Advances in Targeted Protein Degradation
  Chair: Prof. Terry Moore, University of Illinois, US
  
  
• A Focus on Early Career Investigators
  Chair: Dr Melissa Grenier-Davies, GlaxoSmithKline, US
  
  
• Chemical Modulation of RNA
  Chair: Dr Darby Schmidt, Sonata Therapeutics, US
  
  
• Computational Approaches to Identify and Target Cryptic and Allosteric Pockets
  Chair: Dr Malin Lemurell, AstraZeneca, SE

• Drug Targets in GPCR Signalling
  Chair: Prof. György Keseru, Research Centre for Natural Sciences (RCNS), HU
  
  
• Getting Out of the Starting Block: New Hit Finding and Chemotype Advancement Methods
  Chair: Dr Carolyn Dzierba, BMS, US

• Organic Synthesis Impacting Medicinal Chemistry & Chemical Biology
  Chair: Prof. Rui Moreira, University of Lisbon, PT
  
  
• Proximity-inducing Molecules and their Therapeutic Applications
  Chair: Dr Amit Choudhary, Broad Institute, US